| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Forte Biosciences, Inc. | Director | Stock Option (right to buy) | 50K | Aug 20, 2024 | Direct | ||
| Verrica Pharmaceuticals Inc. | Director | Stock Option (right to buy) | 20K | Jun 6, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| FBRX | Forte Biosciences, Inc. | Aug 20, 2024 | 1 | $0 | 4 | Aug 22, 2024 | Director |
| VRCA | Verrica Pharmaceuticals Inc. | Jun 6, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
| FBRX | Forte Biosciences, Inc. | Sep 19, 2023 | 1 | $0 | 4 | Sep 20, 2023 | Director |
| VRCA | Verrica Pharmaceuticals Inc. | Jun 8, 2023 | 1 | $0 | 4 | Jun 12, 2023 | Director |
| VRCA | Verrica Pharmaceuticals Inc. | Jun 9, 2022 | 1 | $0 | 4 | Jun 13, 2022 | Director |
| FBRX | Forte Biosciences, Inc. | Jun 1, 2022 | 1 | $0 | 4 | Jun 2, 2022 | Director |
| FBRX | Forte Biosciences, Inc. | Feb 23, 2022 | 1 | $0 | 4 | Feb 24, 2022 | Director |
| VRCA | Verrica Pharmaceuticals Inc. | Jun 10, 2021 | 1 | $0 | 4/A | Jun 17, 2021 | Director |
| FBRX | Forte Biosciences, Inc. | May 28, 2021 | 1 | $0 | 4 | Jun 1, 2021 | Director |